These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 37496090)

  • 21. Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot.
    Pennypacker SD; Cunnane K; Cash MC; Romero-Sandoval EA
    Front Pharmacol; 2022; 13():921493. PubMed ID: 35734402
    [No Abstract]   [Full Text] [Related]  

  • 22. [Brief history of recent hemp cultivation in Switzerland and subsequent medico-legal problems resulting from hemp cultivation].
    Giroud C; Broillet A; Augsburger M; Bernhard W; Rivier L; Mangin P
    Praxis (Bern 1994); 1999 Jan; 88(4):113-21. PubMed ID: 10067113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delta-8 THC Retail Availability, Price, and Minimum Purchase Age.
    Rossheim ME; LoParco CR; Walker A; Livingston MD; Trangenstein PJ; Olsson S; McDonald KK; Yockey RA; Luningham JM; Kong AY; Henry D; Walters ST; Thombs DL; Jernigan DH
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):363-370. PubMed ID: 36342930
    [No Abstract]   [Full Text] [Related]  

  • 24. Determination of cannabinoids in hemp oil based cosmetic products by LC-tandem MS.
    Hsu YH; Fang MC; Huang SC; Kao YM; Tseng SH; Wang DY
    J Food Drug Anal; 2021 Sep; 29(3):502-509. PubMed ID: 35696248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delta-8 Tetrahydrocannabinol Product Impurities.
    Ray CL; Bylo MP; Pescaglia J; Gawenis JA; Greenlief CM
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing Characteristics and Compliance of Online Delta-8 Tetrahydrocannabinol Product Sellers.
    Nali MC; McMann TJ; Purushothaman V; Li Z; Cuomo RE; Liang BA; Mackey TK
    Cannabis Cannabinoid Res; 2023 May; ():. PubMed ID: 37200462
    [No Abstract]   [Full Text] [Related]  

  • 27. Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitioners.
    Miller OS; Elder EJ; Jones KJ; Gidal BE
    Epilepsy Behav; 2022 Feb; 127():108514. PubMed ID: 34998268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time Trends of Tetrahydrocannabinol (THC) in a 2008-2021 German National Survey of Hemp Food Products.
    Dräger H; Barthlott I; Golombek P; Walch SG; Lachenmeier DW
    Foods; 2022 Feb; 11(3):. PubMed ID: 35159636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiating Cannabis Products: Drugs, Food, and Supplements.
    Salehi A; Puchalski K; Shokoohinia Y; Zolfaghari B; Asgary S
    Front Pharmacol; 2022; 13():906038. PubMed ID: 35833025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.
    Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW
    Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Dark Side of Cannabidiol: The Unanticipated Social and Clinical Implications of Synthetic Δ
    Geci M; Scialdone M; Tishler J
    Cannabis Cannabinoid Res; 2023 Apr; 8(2):270-282. PubMed ID: 36264171
    [No Abstract]   [Full Text] [Related]  

  • 32. Consumer Experiences with Delta-8-THC: Medical Use, Pharmaceutical Substitution, and Comparisons with Delta-9-THC.
    Kruger DJ; Kruger JS
    Cannabis Cannabinoid Res; 2023 Feb; 8(1):166-173. PubMed ID: 34797727
    [No Abstract]   [Full Text] [Related]  

  • 33. Unintentional ingestion of putative delta-8 tetrahydrocannabinol by two youth requiring critical care: a case report.
    Bradley EK; Hoots BE; Bradley ES; Roehler DR
    J Cannabis Res; 2023 Mar; 5(1):9. PubMed ID: 36941718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Raman-Based Differentiation of Hemp, Cannabidiol-Rich Hemp, and Cannabis.
    Sanchez L; Baltensperger D; Kurouski D
    Anal Chem; 2020 Jun; 92(11):7733-7737. PubMed ID: 32401504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory sampling of industrial hemp plant samples (Cannabis sativa L.) using UPLC-MS/MS method for detection and quantification of twelve cannabinoids.
    Berthold EC; Yang R; Sharma A; Kamble SH; Kanumuri SR; King TI; Popa R; Freeman JH; Brym ZT; Avery BA; McCurdy CR
    J Cannabis Res; 2020 Dec; 2(1):42. PubMed ID: 33526142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, Δ9-Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Related Metabolites in Canine Serum After Dosing With Three Oral Forms of Hemp Extract.
    Wakshlag JJ; Schwark WS; Deabold KA; Talsma BN; Cital S; Lyubimov A; Iqbal A; Zakharov A
    Front Vet Sci; 2020; 7():505. PubMed ID: 33102539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consumption and quantitation of delta9-tetrahydrocannabinol in commercially available hemp seed oil products.
    Bosy TZ; Cole KA
    J Anal Toxicol; 2000 Oct; 24(7):562-6. PubMed ID: 11043660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Types and Brands of Derived Psychoactive Cannabis Products: An Online Retail Assessment, 2023.
    Rossheim ME; Tillett KK; Vasilev V; LoParco CR; Berg CJ; Trangenstein PJ; Yockey RA; Sussman SY; Siegel M; Jernigan DH
    Cannabis Cannabinoid Res; 2024 Jan; ():. PubMed ID: 38237125
    [No Abstract]   [Full Text] [Related]  

  • 39. Concentrations of THC, CBD, and CBN in commercial hemp seeds and hempseed oil sold in Korea.
    Jang E; Kim H; Jang S; Lee J; Baeck S; In S; Kim E; Kim YU; Han E
    Forensic Sci Int; 2020 Jan; 306():110064. PubMed ID: 31786513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Industry-Based Misconceptions Regarding Cross-Pollination of
    Olejar KJ; Park SH
    Front Plant Sci; 2022; 13():793264. PubMed ID: 35154220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.